#JCLSpotlight: Current lipid-lowering therapies have only modest impact on Lp(a), but new RNA-targeted agents are showing promise. Pelacarsenโan antisense oligonucleotideโreduced Lp(a) by โฅ80% in phase 2b and is now in multiple phase 3 trials.
Read more: ow.ly/T6Jy50XBZhz
04.12.2025 16:55 โ ๐ 2 ๐ 0 ๐ฌ 0 ๐ 0
๐ฃNEW expert clinical review from the NLA on #FCS.
๐Read the full-length article: ow.ly/ALrc50VBAv6
16.04.2025 13:13 โ ๐ 4 ๐ 4 ๐ฌ 0 ๐ 0
Don't miss our latest JCL Roundtable!๐ฃ๏ธ Drs. Carol F. Kirkpatrick, Kristina S. Petersen, Michael J. Wilkinson, & Kevin C. Maki discuss dietary recommendations for #ASCVD prevention. Read the conversation๐ lipidjournal.com/article/S1933-2874(25)00052-2/fulltext #cardiosky
11.04.2025 19:05 โ ๐ 0 ๐ 3 ๐ฌ 0 ๐ 0
๐ขNEW NLA & AGS expert clinical consensus on managing #hypercholesterolemia in adults older than 75 years without a history of #ASCVD.
Read the article now: sciencedirect.com/science/arti...
#Cardiosky
10.04.2025 18:55 โ ๐ 3 ๐ 4 ๐ฌ 0 ๐ 1
Thank you so much!
13.12.2024 21:18 โ ๐ 1 ๐ 0 ๐ฌ 0 ๐ 0